[144] Houlihan Lokey, Inc. SEC Filing

Rhea-AI Filing Summary

Houlihan Lokey, Inc. filed a Form 144 indicating a proposed sale of 200 common shares through Morgan Stanley Smith Barney on 14 July 2025. The aggregate market value of the shares to be sold is $37,918, versus 53,789,857 shares outstanding, representing a negligible 0.0004% of total shares.

The filer previously executed two Rule 10b5-1 sales for the same account—200 shares on 13 June 2025 for $34,874 and 200 shares on 13 May 2025 for $35,692. The securities being sold were acquired as restricted stock on 26 May 2021. No material adverse information was acknowledged by the seller, as required under Rule 144 representations.

This notice reflects routine insider share disposition activity. The transaction size is immaterial relative to market capitalization and does not appear to signal a strategic change or financial stress for HLI.

Insights

Securities Analyst

TL;DR: Routine Form 144 for 200 shares; immaterial insider sale—neutral impact.

The filing discloses a proposed sale of 200 HLI shares (~$38k) plus history of two similar 200-share trades over the past three months. With 53.8 million shares outstanding, the cumulative 600-share disposition equals roughly 0.001% of equity, far below thresholds that generally alter insider-sentiment assessments. No information suggests unusual timing or undisclosed negative developments; the shares were originally granted as restricted stock in 2021. Overall, the event is non-material and should not affect valuation or liquidity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	200	37918.00	53789857	07/14/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/26/2021	Restricted Stock Shares	Issuer			200	05/26/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for GILLIAN ZUCKER 10250 Constellation Blvd, 5th Floor Los Angeles CA 90067	Common	06/13/2025	200	34874.00
10b5-1 Sales for GILLIAN ZUCKER 10250 Constellation Blvd, 5th Floor Los Angeles CA 90067	Common	05/13/2025	200	35692.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Houlihan Lokey (HLI) disclose in the latest Form 144?

The company reported a proposed sale of 200 common shares valued at $37,918 scheduled for 14 July 2025.

How significant is the 200-share sale compared with HLI's total shares outstanding?

The sale equals about 0.0004% of the 53,789,857 shares outstanding—an immaterial amount.

Were there other insider sales recently disclosed?

Yes. The filer sold 200 shares on 13 June 2025 for $34,874 and 200 shares on 13 May 2025 for $35,692.

What type of shares are being sold and when were they acquired?

They are restricted stock shares acquired on 26 May 2021.

Which broker is handling the proposed July 2025 sale?

The broker of record is Morgan Stanley Smith Barney LLC.